fbpx Yourgene Health plc - Home
Image is not available
Expertise  / Partnership / Comprehensive
previous arrow
next arrow
Slider

Why choose CF-EU2v1?

  • CE-IVD ensures reliability
  • Clinically relevant with 80-90% coverage of the most prevalent mutations (region dependent)
  • Available population-specific bolt on panels
  • Fast turnaround time
  • Simple set up, minimal hands on time and ease of use
  • Fits comfortably into existing patient care pathways, with low  DNA input volume
  • Users can expect consistency across results – ease of interpretation
  • Data review using GeneMapper and GeneMarker software (no data transfer required)

Performance you can rely on
100% Accuracy, Repeatability & Reproducibility

 Positive Percent Agreement (PPA)Negative Percent Agreement (NPA)Overall Agreement (OA)

Accuracy

100%

100%

100%

Repeatability

100%

100%

100%

Reproducibility

100%

100%

100%

Accuracy was compared to Sanger sequencing. Accuracy of the CF-EU2v1 assay was assessed by evaluating 159 samples representing a wide variety of CFTR gene variants from 4 separate sources.